Police: No Evidence Lanza on Medication

From the evidence gathered so far, it appears that Adam Lanza, the murderer of 27 people in Newtown, Connecticut, was not taking any medication. In a search of the Lanza home he shared with his mother, cellphones, computers and computer games were found – but no medication.

Lanza’s parents had spoken of his diagnosis with Asperger’s syndrome, but that disease has no connection with violent behavior.

Former FBI agent Robert Paquette said:

They are looking at everything. They are poring over anything and everything. Was he on meds? Did he go off meds? How was his relationship with his mother? What video games did he play? How often did he play? Where did he learn to shoot? How often did he shoot? ... Forensics are going to tell us who died where and when. What they want to determine is why.

Experts are trying to determine what other diseases might have affected Lanza; Dr. H. Wayne Carver, the chief state medical examiner, said he is consulting with a geneticist at the University of Connecticut to find out "if there is any identifiable disease associated with this behavior."

If it is true that Lanza took no medication, the question remains: why wasn’t he taking anything? Was he getting appropriate care? And if Nancy Lanza wanted to involuntarily commit her son, was he even receiving psychiatric treatment?



Comments

advertisement

The past several months have seen the price of gold slump even as the Fed and other central banks have accelerated their massive expansion of paper money. Gold is off about 20% so far this year with silver down almost 30%. The old adage--“don’t fight the Fed”--particularly comes to mind now because the US equity markets have been setting new highs during this same period. All of these gains are nominal, you understand, but for terrified American policy makers and investors, nominal is just fine.

Full Article

Send A Tip

Most Popular

advertisement

Breitbart Video Picks

Fox News National

advertisement

Sign up for our newsletter

advertisement

From Our Partners